Nucynta 50 mg/1 (Tapentadol Hydrochloride TABLET, FILM COATED) 50 mg/1

Nucynta 50 mg is a prescription medication containing tapentadol hydrochloride, used for managing moderate to severe pain. This oral tablet is designed to provide effective pain relief.

Strength

50 mg/1

Pack Size

100 TABLET, FILM COATED in 1 BOTTLE (24510-050-10)

Manufacturer / TM Owner

Collegium Pharmaceutical, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nucynta 50 mg is primarily used for the management of moderate to severe pain. It is often prescribed for conditions that require around-the-clock pain relief. The active ingredient, tapentadol hydrochloride, works by affecting the way the body perceives pain. People often ask, 'What is Nucynta used for?' and the answer is typically for chronic pain conditions that need consistent management.

Side Effects

Common effects of Nucynta 50 mg may include dizziness, nausea, and constipation. Some users might experience drowsiness or vomiting. These effects can vary from person to person and are not exhaustive. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Nucynta 50 mg should be handled with care. It is important to follow the prescribed dosage and instructions provided by a healthcare professional. This medication should be stored securely to prevent misuse. Pregnant or breastfeeding women should discuss the use of Nucynta with their doctor.

Avoid Interactions

Nucynta 50 mg may interact with other medications, including alcohol and certain antidepressants. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow medical advice regarding the use of Nucynta.

Frequently Asked Questions

Nucynta 50 mg is used for managing moderate to severe pain that requires around-the-clock treatment.

Nucynta 50 mg should be taken orally, following the instructions provided by your healthcare provider.

Common side effects may include dizziness, nausea, and constipation. Always consult a healthcare provider for personalized advice.

Nucynta 50 mg may interact with other medications, so it is important to discuss all your medications with your healthcare provider.

Pregnant or breastfeeding women should consult their doctor before using Nucynta 50 mg.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.